ABSTRACT

Error-proofing in the production process of pharmaceuticals isn‘t just a matter of good business, it has life-and-death implications for consumers. The 2013 Drug Quality and Security Act introduces more stringent compliance factors towards this common goal, in large part requiring new mandates on tracking and tracing chain of custody in the supply chain. This book comprehensively overviews the new mandate and its implications, including implementation strategies for track-and-trace programs along with presenting a fuller understanding of the mechanics of intergovernmental policies and oversights.

chapter 4|18 pages

Track and Trace: Not Hide and Seek

chapter 5|18 pages

Land of the Giants—and Land of the Totes

chapter 10|16 pages

Drug Quality and Security Hall of Fame